Interactive Transcript
0:00
This was another woman who had right-sided visual loss.
0:05
We're looking at the axial T2-weighted scans that
0:08
went through the orbits, as well as the coronal
0:11
post-gadolinium-enhanced scans.
0:13
These were done as part of a multiple sclerosis evaluation,
0:17
and therefore, you will have T2-weighted scans,
0:20
FLAIR scans, as well as post-gadolinium-enhanced scans.
0:24
And generally, in this situation,
0:26
the cervical thoracic spine is also evaluated
0:29
for the potential for spinal lesions.
0:32
As we scroll the T2-weighted scan, we identify an area
0:35
of abnormal signal intensity within the optic nerve.
0:40
Again, we are able to see the optic nerve sheath with the
0:42
bright CSF, as well as the optic nerve with the area
0:47
of abnormal signal intensity on the right side.
0:51
Be careful about partial volume averaging of CSF,
0:54
which could simulate demyelination of the optic nerve.
0:58
We also note that the optic nerve is not enlarged in size,
1:04
and this is typical of patients with optic neuritis.
1:07
Occasionally, they will have optic nerve enlargement,
1:09
but generally, not to the same extent
1:11
that we consider a neoplasm.
1:14
As we move to the coronal post-gadolinium
1:17
fat-suppressed scan,
1:18
we see the abnormal optic nerve
1:21
showing contrast enhancement.
1:23
We contrast this with the normal optic nerve on
1:27
the left side, showing absence of enhancement.
1:30
Let's scroll through these images, as well.
1:33
We follow the optic nerve posteriorly, and we see
1:37
that it is showing diffuse enhancement, and yet,
1:40
does not appear to be particularly enlarged.
1:43
It does appear that the cerebrospinal fluid,
1:46
within the optic nerve sheath complex,
1:49
is also showing contrast enhancement.
1:51
And this is what some people would call perioptic neuritis,
1:56
inflammation of the sheath with the gadolinium-enhanced sequence.
2:01
Note, however, that on the contralateral side, you also see some
2:06
element of faint enhancement of the optic nerve sheath
2:10
without affecting the optic nerve.
2:13
Continuing to scroll more posteriorly,
2:15
we follow it to the optic canal.
2:19
How do we identify the optic canal?
2:22
Usually, the optic canal is best identified by seeing the
2:25
anterior clinoid process. You see the cortex,
2:28
the dark signal intensity of the anterior clinoid
2:31
process, and the bright signal intensity
2:33
of the bone marrow, in this instance.
2:35
Here we have the cortex of the anterior
2:37
clinoid process as well.
2:39
The optic nerve canal is medial to the anterior
2:43
clinoid process, and we are identifying the optic nerve,
2:48
showing contrast enhancement on the right side,
2:51
as opposed to the left side.
2:54
As we scroll further posteriorly,
2:57
we're going to come to the prechiasmal optic nerve,
3:00
and then the optic chiasm.
3:02
These do not show contrast enhancement.
3:08
As I said, this patient was being evaluated
3:11
with known multiple sclerosis,
3:13
and therefore, we want to look
3:14
at the images of the brain.
3:17
I'm going to pull down the FLAIR scan,
3:20
which is the most sensitive for demyelination
3:22
in the brain.
3:24
In a woman in the 30s,
3:26
we would not expect to see white matter lesions.
3:30
And as you can see in this patient,
3:32
we immediately identified two lesions in the white matter,
3:37
juxtacortical in location on the right side.
3:44
As we continue to scroll,
3:45
we are looking for periventricular white matter lesions.
3:49
The reason for this is that to make the
3:51
diagnosis of multiple sclerosis,
3:53
the McDonald criteria require us to identify
3:57
demyelinating plaques in two of four locations,
4:01
those being juxtacortical, periventricular,
4:06
infratentorial, and in the posterior fossa or in the spine.
4:10
As of right now,
4:12
we have identified juxtacortical white matter lesions,
4:15
but the periventricular white matter looks clean.
4:20
For the evaluation of the posterior fossa,
4:23
we generally say that T2-weighted imaging is
4:26
superior to FLAIR imaging for identifying
4:29
demyelinating plaques.
4:32
So, let's pull down the T2-weighted scan
4:36
and look at the posterior fossa.
4:38
So I'm magnifying to the posterior fossa,
4:40
and we look at the brainstem and the cerebellum,
4:43
and we see there are no demyelinating
4:46
plaques in the posterior fossa.
4:48
So we cannot make the diagnosis of multiple sclerosis yet,
4:51
because we've only fulfilled one of the four McDonald criteria,
4:55
the juxtacortical white matter lesions.
4:59
The next thing to do would be to scan
5:01
the cervical thoracic spine.
5:05
In general,
5:06
T2-weighted imaging or STIR imaging are the best
5:10
pulse sequences to identify demyelinating
5:13
plaques in the spinal cord.
5:16
I generally prefer the T2-weighted scans,
5:20
without STIR imaging, because of the relative absence of
5:25
phase ghosting artifacts on the traditional T2-weighted scan,
5:29
as opposed to the FLAIR scans.
5:32
However, the FLAIR scans offer very good contrast
5:35
as well for looking at demyelinating plaques.
5:39
What one sees on this STIR image is an area of
5:43
abnormal signal intensity at the C2 level
5:46
of the cervical spinal cord.
5:49
We want to confirm that on axial T2-weighted imaging.
5:54
We also want to perform post-gadolinium-enhanced scans,
5:57
to identify whether this plaque is
6:00
showing activity with breakdown of the blood-brain
6:03
barrier, or in this case, the blood-spinal barrier,
6:07
that might suggest that there is active
6:08
demyelination going on.
6:10
If there is, more likely that
6:12
the neurologist will treat the patient acutely.
6:15
So by virtue of identifying a lesion in the spinal cord,
6:19
we now have met the McDonald criteria
6:21
in two out of the four areas.
6:24
A word of note. If you are viewing this from Europe,
6:28
the Magnims Convention is to include optic neuritis
6:34
as one of the four criteria for making the diagnosis
6:39
of multiple sclerosis.
6:41
In America, we have not yet adopted optic neuritis
6:44
as one of the four McDonald criteria.
© 2024 Medality. All Rights Reserved.